Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Special Report Awards Gala Trending Oncology Awards CRO Awards Innovation Awards Pharma Marketing Awards Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Special Report Awards Gala Trending Oncology Awards CRO Awards Innovation Awards Pharma Marketing Awards Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Stories Sponsored The World Can’t Wait: Delivering on the Promise of Biopharma’s “Golden Age” Mina Makar, Senior Vice President, Global Cardiovascular, Renal and Metabolism, AstraZeneca BIO 2025 showed the science is ready—now it’s time to ensure access, equity, and impact for patients. Sponsored An additional treatment option with TAGRISSO® (osimertinib) Learn about a treatment option with TAGRISSO® (osimertinib). Sponsored AstraZeneca's vision for the future of respiratory care AstraZeneca's Maria Belvisi explores innovative approaches in respiratory medicine, from AI-driven trials to next-gen therapeutics. Sponsored Climate change: What role does healthcare play? Following a successful visit to COP 28 in Dubai, AstraZeneca’s Pam Cheng describes a watershed moment that provides cause for excitement in 2024. Sponsored AstraZeneca’s commitment to lung cancer and improving patient outcomes AstraZeneca’s Dr. Arun Krishna discusses the company’s work in the field of lung cancer and the importance of early detection.
Sponsored The World Can’t Wait: Delivering on the Promise of Biopharma’s “Golden Age” Mina Makar, Senior Vice President, Global Cardiovascular, Renal and Metabolism, AstraZeneca BIO 2025 showed the science is ready—now it’s time to ensure access, equity, and impact for patients.
Sponsored An additional treatment option with TAGRISSO® (osimertinib) Learn about a treatment option with TAGRISSO® (osimertinib).
Sponsored AstraZeneca's vision for the future of respiratory care AstraZeneca's Maria Belvisi explores innovative approaches in respiratory medicine, from AI-driven trials to next-gen therapeutics.
Sponsored Climate change: What role does healthcare play? Following a successful visit to COP 28 in Dubai, AstraZeneca’s Pam Cheng describes a watershed moment that provides cause for excitement in 2024.
Sponsored AstraZeneca’s commitment to lung cancer and improving patient outcomes AstraZeneca’s Dr. Arun Krishna discusses the company’s work in the field of lung cancer and the importance of early detection.
